MedPath
NMPA Approval

Fluticasone Propionate Inhalation Aerosol

国药准字HJ20130190

December 27, 2023

H20130190

Drug Information

丙酸氟替卡松吸入气雾剂

辅舒酮

吸入气雾剂

每瓶60揿,每揿含丙酸氟替卡松125μg,递送剂量为丙酸氟替卡松110μg;每瓶120揿,每揿含丙酸氟替卡松125μg,递送剂量为丙酸氟替卡松110μg

化学药品

December 27, 2023

October 15, 2028

Company Information

Applicant Company

GLAXOSMITHKLINE SA

Severo Ochoa, 2, 28760 Tres Cantos (Madrid), Spain

Manufacturing Company

Glaxo Wellcome SA

Avda de Extremadura 3 Poligono Industrial Allenduero Aranda De Duero, Burgos, 09400 Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

丙酸氟替卡松吸入气雾剂 - NMPA 批准文号 | MedPath